UPLC-MS/MS Method for Determination of Khasianine in Mouse Blood: Application for Its Pharmacokinetic Study

Current Pharmaceutical Analysis
2020.0

Abstract

Background: The aim of this study was to determine the concentrations of khasianine in mouse whole blood sample and its application for the pharmacokinetics by a rapid, selective and sensitive ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) method. Methods: The blood samples were preprocessed by one-step protein precipitation with acetonitrile. The study was performed on an ACQUITY I-Class UPLC system with a UPLC BEH column. Lannaconitine (internal standard, IS) and khasianine were gradient eluted by a mixture of acetonitrile and water with 0.1% formic acid at a flow rate of 0.4 mL/min. The mass spectrometer was equipped with an Elec-trospray Ionization (ESI) source in positive mode. The quantitative detection was performed in a multiple reaction monitoring modes at transitions m/z 722.4→70.7 for khasianine and m/z 585.3→119.9 for the corresponding IS. Results: The calibration curve was of good linearity ranging from 0.5 to 1000 ng/mL (r >0.995). The Lower Limit of Detection (LLOD) and Lower Limit of Quantitation (LLOQ) were 0.2 and 0.5 ng/mL, respectively. The inter-day and intra-day precision (RSD%) were both less than 14%, and the accuracy ranged from 86.6% to 108.3%. The matrix effects were between 98.0% and 103.7%, and the average recovery was better than 67.4%. Conclusion: This assay established a sensitive, rapid, selective UPLC-MS/MS method which was successfully used for the pharmacokinetic study of khasianine in mouse blood, and the absolute availability of khasianine was 0.78% which exhibited a poor oral absorption. © 2020 Bentham Science Publishers.

Knowledge Graph

Similar Paper

UPLC-MS/MS Method for Determination of Khasianine in Mouse Blood: Application for Its Pharmacokinetic Study
Current Pharmaceutical Analysis 2020.0
Pharmacokinetics and bioavailability of liensinine in mouse blood by UPLC-MS/MS
Acta Chromatographica 2021.0
Development of a simple and rapid UPLC-MS/MS method for determination of 8-deacetyl-yunaconitine in rat plasma and its application to pharmacokinetics
Journal of Pharmaceutical and Biomedical Analysis 2021.0
Determination of narciclasine in mouse blood by UPLC-MS/MS and its application to a pharmacokinetic study
Acta Chromatographica 2021.0
Determination and pharmacokinetics of calycanthine in rat plasma by UPLC-MS/MS
Acta Chromatographica 2020.0
A validated UHPLC-MS/MS method for measurement of pharmacokinetics and tissue distribution of trolline in rat
Journal of Pharmaceutical and Biomedical Analysis 2019.0
Pharmacokinetic and bioavailability study of 5‐hydroxy‐4‐methoxycanthin‐6‐one, a typical canthinone alkaloid, in rats using ultra‐high performance liquid chromatography/electrospray ionization tandem mass spectrometry
Biomedical Chromatography 2020.0
Pharmacokinetics of 10-Hydroxy Mesaconitine in Rat Plasma by Ultra-Performance Liquid Chromatography-Tandem Quadrupole Mass Spectrometry
Journal of Analytical Methods in Chemistry 2021.0
Investigation of preclinical pharmacokinetics of N-demethylsinomenine, a potential novel analgesic candidate, using an UPLC-MS/MS quantification method
Frontiers in Chemistry 2023.0
Development and Validation of a Sensitive UHPLC-MS/MS Method for the Measurement of Gardneramine in Rat Plasma and Tissues and Its Application to Pharmacokinetics and Tissue Distribution Study
Molecules 2019.0